This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version/Version mobile   RSS   Unsubscribe/Désabonner   Archive   Media Kit/Trousse média
|   AhHa B2B Search:      Nov. 13, 2012

Home/Accueil         Contact Us/Nous contacter

 

Canada is the Guest Nation — AAOS 2013
COA    Share   Share on FacebookTwitterShare on LinkedinE-mail article

Canada will be honoured as the 2013 Guest Nation at the upcoming American Academy of Orthopaedic Surgeons (AAOS) meeting being held in Chicago from Mar. 19-23.

Meeting attendees can look forward to a special video presentation during the event's Opening Ceremonies, a Guest Nation scientific poster exhibit, a reception for COA members and a Guest Nation exhibit booth. Be sure to visit the exhibit booth where the COA staff and leadership will be distributing special 'Canada Guest Nation' ribbons to attach to your meeting name badge.

Stay tuned for more information about the Canada Guest Nation activities.




Le Canada est le pays invité au Congrès 2013 de l'AAOS
COA    Share   
On a choisi d'inviter le Canada au prochain congrès annuel de l'American Academy of Orthopaedic Surgeons (AAOS), qui aura lieu à Chicago, du 19 au 23 mars. Les participants auront droit à une vidéo spéciale, diffusée aux cérémonies d'ouverture, de même qu'à une exposition d'affiches scientifiques et à un stand du Canada, sans compter la tenue d'une réception à l'intention des membres de l'ACO. Assurez-vous de passer par le stand du Canada où des membres du personnel et de la direction de l'ACO remettront des rubans « Canada Guest Nation » (représentant du pays invité), à fixer à votre porte-nom. On communiquera bientôt de plus amples renseignements sur les activités entourant le statut de pays invité.

 Conferences of Interest / Congrès d’intérêt

Competency Based Training Program: A Practical Approach to Competency-Based Education in Your Residency Training Program: From Concept to Implementation
This one-day workshop will be held on Apr. 30, 2013 in Toronto. The workshop will feature: 1) how to design a competency-based curriculum, including an introductory surgical skills bootcamp, 2) how to build state-of-the-art, user-friendly tools for the evaluation of competence, 3) lessons learned from the University of Toronto Orthopaedics Competency-Based Curriculum pilot project, 4) Q&A sessions with Module Leaders from the Competency-Based Curriculum, 5) Break-out sessions with Module Leaders to develop customized competency-based modules for your own residency program. Complete information can be found at: www.competency-based-training.com


BioniCare®

BioniCare is a non-drug, non-invasive solution for osteoarthritis of the knee and rheumatoid arthritis of the hand. BioniCare has been clinically proven to reduce the pain and symptoms of arthritis and defer total knee replacement surgery. Find out if this conservative treatment is right for your patients. Contact us at cturner@bellnet.ca or 1-800-661-5329  more


 In the News / Dans les nouvelles


Quebec government: Two-tier health care is here, and we don't want it
Global News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Quebec government says two-tier health care is a reality in the province and that needs to change. The statement from the health minister came after a report from the provincial ombudsman that lamented the gap between what Quebecers are told about their health system and what actually exists. Health Minister Rejean Hebert conceded that it does appear that some people are getting faster access to service with their credit card. "There is a problem with two-tier health care in Quebec," Hebert told reporters. "I think it's unacceptable." He said the phenomenon stems from deficiencies in the public system that must be addressed, with better front-line care and access to radiology and other services. He said the PQ plans to increase the number of family doctors by 170, and improve access for 750,000 people. More



Les fabricants de médicaments génériques pourront produire des copies
Le Journal de Montréal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Dans une décision unanime, la Cour suprême du Canada invalide le brevet de fabrication canadien du Viagra, et permet aux fabricants de médicaments génériques d'en produire une copie pour la vente en pharmacie. La cause opposait la compagnie pharmaceutique Teva Canada Ltée, anciennement Novopharm, au fabricant du Viagra, Pfizer Canada. Teva alléguait que le brevet du médicament oral pour traiter la dysfonction érectile était invalide parce qu'il ne divulguait pas les informations précises à propos de son invention, comme le stipule la Loi sur les brevets, notamment au sujet du sildénafil, considéré comme l'élément actif du Viagra. Le plus haut tribunal du pays précise dans sa décision qu'une compagnie qui obtient un brevet pour son invention doit, en retour d'un monopole sur le produit pendant une période déterminée, divulguer des informations sur son fonctionnement et expliquer en quoi consiste le produit. More



OrthoEvidence Newsletter / Bulletin OrthoEvidenceMC






 
COA Dispatch / Dépêche de l'ACO
Cynthia Vezina, Manager, Communications & Membership Services
coa-aco.org

Frank Humada, Director of Publishing, 289.695.5422
Download media kit

Joanne Lam, Content Editor, 289.695.5474   
Contribute news

This edition of COA Dispatch was sent to ##Email##. To unsubscribe, click here.

Cette édition du Dépêche de l'ACO a été envoyé à ##Email##. Pour vous désabonner, cliquez ici.
Recent issues






50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8